mRNA |
erlotinib:PLX-4032 (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.016 |
0.7 |
mRNA |
UNC0638:navitoclax (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.015 |
0.7 |
mRNA |
myricetin |
CTRPv2 |
pan-cancer |
AAC |
-0.015 |
0.7 |
mRNA |
selumetinib:UNC0638 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.014 |
0.7 |
mRNA |
BRD-K78574327 |
CTRPv2 |
pan-cancer |
AAC |
0.028 |
0.7 |
mRNA |
CIL55 |
CTRPv2 |
pan-cancer |
AAC |
0.023 |
0.7 |
mRNA |
navitoclax:gemcitabine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.013 |
0.7 |
mRNA |
semagacestat |
CTRPv2 |
pan-cancer |
AAC |
-0.014 |
0.7 |
mRNA |
CD-437 |
CTRPv2 |
pan-cancer |
AAC |
0.012 |
0.7 |
mRNA |
Curcumin |
CTRPv2 |
pan-cancer |
AAC |
0.013 |
0.7 |